News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
According to survey results presented at ASHG, most genetics experts support somatic and germline gene editing, though few favor trait enhancement.
The collaborators will grant the licenses to any entities wanting to use the technology for commercial agricultural research and product development.
The perturbed genes will be identified by barcodes associated with single guide RNAs, and read using an in situ sequencing method.
Among the winners are a number of investigators who will receive funding to support omics-focused research.
The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.
Using DNA to sketch crime victims might not be a great idea, the NYTimes says.
Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.